MedDataX Logo

Evaluation of the Signals Electrophysiological Measured by Intelligent Textiles

NCT ID: NCT03805243

Last Updated: 2021-11-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-29

Study Completion Date

2020-12-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

BioSerenity suggests developing innovative solutions, from intelligent clothes which can be used in a hospital environment or at home. These textiles allow, in particular, to measure the biophysiological signals while letting to the participant the freedom pursue its daily activities.

BioSerenity has already developed two wearable wireless and portable medical devices: cardioskin with textile ECG electrods , and the Neuronaute with textile EEG, EMG electrods.

The aim of the study is to test these sensors to optimize their signal to integrate them in future Bioserenity devices like a somnonaute to help diagnosis of sleep disorders, like uronaute to help diagnosis of urination disorders, like toconaute to help monitoring of pregnancy. Others CE-marked sensors developed by others manufacturers will be tested to choose those that will be integrated in the Bioserenity devices.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The various alone sensors tested in the clinical trial (sensors of Bioserenity and the other manufacturers), will supply information which will allow to develop future devices. Some of these sensors will then be selected to integrate them.

The tests will be made according to the therapeutic area of the concerned device(plan). There are 5 therapeutic areas:

Cardiovascular (Cardioskin device), neurology ( Neuronaute device), urology ( Uronaute device), obstetrics ( Toconaute device), somnologie (Somnonaute device).

One subject would likely test either one sensor of a device or multiple sensors, either an entire device.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

All subject would likely test each the 5 devices
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

test of sensors for somnonaute device

monitoring with sensors

Group Type EXPERIMENTAL

test of sensors for somnonaute device

Intervention Type DEVICE

test of sensors

test of sensors for uronaute device

monitoring with sensors

Group Type EXPERIMENTAL

test of sensors for uronaute device

Intervention Type DEVICE

test of sensors

test of sensors for toconaute device

monitoring with sensors

Group Type EXPERIMENTAL

test of sensors for toconaute device

Intervention Type DEVICE

test of sensors

test of sensors for cardioskin device

monitoring with sensors

Group Type EXPERIMENTAL

test of sensors for cardioskin device

Intervention Type DEVICE

test of sensors

test of sensors for neuronaute device

monitoring with sensors

Group Type EXPERIMENTAL

test of sensors for neuronaute device

Intervention Type DEVICE

test of sensors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

test of sensors for somnonaute device

test of sensors

Intervention Type DEVICE

test of sensors for uronaute device

test of sensors

Intervention Type DEVICE

test of sensors for toconaute device

test of sensors

Intervention Type DEVICE

test of sensors for neuronaute device

test of sensors

Intervention Type DEVICE

test of sensors for cardioskin device

test of sensors

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women or men \>18 years
* affiliation to a social security system

Exclusion Criteria

* Wounds or wounds on the body and the scalp;
* Refusal of consent, minor
* Not membership to the Social Security
* Participant not capable of following the procedure of use (according to the judgment of the investigator);
* Brain surgery that took place less than a week ago
* Allergy known about the money, the polyamide, the silicone, the synthetic materials;
* Sensory Disorders(Confusions) returning the insensible subject to the pain;
* Motor or mental disorders preventing the subject from expressing his pain;
* Behavioral problems that make the subject excessively agitated or aggressive;
* People with cardio-respiratory problems likely to be aggravated by the slight compression of the thorax;
* Subject equipped with an electrical stimulation device;
* Unsuitable anthropometric Parameters (for the women, the sizes superior to 24 will be excluded and for the men(people) those superior to 34);
* Pregnancy clinically detectable or known for the subject;
* Current(in class) Participation in a clinical trial or participation in a previous clinical trial understanding(including) a period of not past(over) deficiency at the time of this clinical trial.
* Predisposition in the headaches of tension (the compression exercised by the hat(cap) can activate(start) in certain cases a headache);
* Use of the device(plan) within the framework of a resuscitation or of intensive care;
* Participating carrier of a defibrillator, a stimulating of the vagus nerve, or quite different surgical high-frequency device.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

BioSerenity

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

quang TRAN

Role: STUDY_DIRECTOR

BioSerenity

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Du Cerveau Et de La Moelle Epiniere

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A02535-48

Identifier Type: -

Identifier Source: org_study_id